Please Wait
Applying Filters...
menu
    • menu
    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    Kikkoman Biochemifa Company advances global health and safety through precision-driven innovation in biotech and food testing.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-10-20

    Virtual Booth

    An Enquiry

    Menu

    TRE-515

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Trethera Ph 1 Data Shows Broad Safety, Strong Target Engagement
    Trethera Ph 1 Data Shows Broad Safety, Strong Target Engagement

    28 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/28/3175581/0/en/Trethera-Successfully-Completes-Phase-1-Dose-Escalation-Trial-Demonstrating-Broad-Therapeutic-Window-Favorable-Safety-and-Confirmed-Target-Engagement.html

    GLOBENEWSWIRE
    28 Oct 2025
    Share Share
    Trethera Gets $1.8M NIH Grant for TRE-515 Crohn’s Therapy
    Trethera Gets $1.8M NIH Grant for TRE-515 Crohn’s Therapy

    23 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/23/3154884/0/en/Trethera-Receives-1-8-Million-NIH-Grant-to-Advance-TRE-515-Development-for-Crohn-s-Disease.html

    GLOBENEWSWIRE
    23 Sep 2025
    Share Share
    Trethera Completes Phase 1 Trial Enrollment for Solid Tumors
    Trethera Completes Phase 1 Trial Enrollment for Solid Tumors

    10 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/10/3147926/0/en/Trethera-Successfully-Completes-Enrollment-of-Phase-1-Dose-Escalation-Trial-for-Patients-with-Solid-Tumors.html

    GLOBENEWSWIRE
    10 Sep 2025
    Share Share